MarketPulse

biotech collaboration

2 articles
BenzingaBenzinga··Vandana Singh

Takeda Exits Dementia Drug Partnership With Denali in Strategic Shift

Takeda exits dementia drug partnership with Denali Therapeutics on DNL593. Denali regains full control, plans Phase 1/2 data release by end-2026. Denali shares fell 3.73%.
TAKDNLIPhase 1/2 trialbiotech collaboration
BenzingaBenzinga··Bamboo Works

Jacobio Pharma Eyes 2026 Profitability on AstraZeneca Deal and Cancer Drug Sales

Chinese biotech Jacobio Pharmaceuticals expects profitability in 2026 via $100M AstraZeneca deal for KRAS inhibitor and growing Glecirasib sales.
AZNprofitabilitylicensing agreement